NVZMF
NOVOZYMES AS/FIPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVZMF
this stock
NOVOZYMES AS/FI
|
$29.86B | +3.8% | — | — | 0.6% |
|
LIN
Linde PLC
|
$248.98B | +26.7% | +3.0% | 35.7 | 1.6% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.34B | +5.8% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$84.41B | +6.1% | +26.4% | 32.9 | 3.7% |
|
ECL
Ecolab Inc.
|
$79.67B | +8.1% | +2.2% | 38.3 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVZMF | +5.7% | +13.6% | -0.6% | +5.7% | +3.9% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +4.8% | +12.3% | -8.1% | +5.6% | -5.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.